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ABSTRACT 
Blood-brain barrier (BBB) and neurotrophic factors seemingly have an important role in multiple 
sclerosis pathology. Physical activity may influence blood-brain barrier function and levels of 
neurotrophic factors, and such effects might be moderated by body weight status. This study 
investigated the effect of exercise training on markers of blood-brain barrier permeability and 
neurotrophic factors as a function of weight status in multiple sclerosis patients.  Sixty three 
persons with relapsing remitting multiple sclerosis who were normal weight (n: 33) or overweight 
(n: 33) were randomly assigned into groups of exercise (normal weight training, n: 18; overweight 
training group, n: 18) or no exercise (normal weight control, n: 15; overweight control group, n: 
15). The intervention consisted of 8 weeks (3 days per week) of cycling undertaken at 60-70% 
peak power. Resting blood concentrations of s100 calcium-binding protein B (s100b) and neuron-
specific enolase as BBB permeability markers, neurotrophic factors and cytokines (Interleukin-10 
and tumor necrosis factor alpha) were evaluated before and after the intervention. There were 
significant weight, training, and interaction effects on brain-derived neurotrophic factor and 
platelet-derived growth factor; however, ciliary neurotrophic factor and nerve growth factor did 
not demonstrate any effect. Brain-derived neurotrophic factor and platelet-derived growth factor 
were significantly increased from pre-post in normal weight exercise. Significant weight, training, 
and interaction effects were found for s100b. In detail, s100b was significantly increased from pre-
post in normal weight exercise. In contrast, neuron-specific enolase and cytokines did not 
demonstrate any effect. Generally, Exercise training may alter markers of BBB permeability and 
neurotrophic factor status in normal weight persons with multiple sclerosis; however, overweight 
participants may be more resistant to these effects of exercise. 
Keywords: Blood-brain barrier, Neurotrophic factors, Cytokine, Exercise, Excess weight, Multiple 
sclerosis 
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1. Introduction 
Multiple sclerosis is a common and unpredictable neurological disease of the central nervous 
system (CNS) (Mokhtarzade et al., 2017). The cause of multiple sclerosis is currently unknown, 
but seemingly involves an environmental trigger of the immune system that results in 
demyelination and impaired remyelination processes with the CNS of genetically susceptible 
persons (Motl and Pilutti, 2012; Motl et al., 2017). Such an immune-mediated process involves 
disruption of the blood-brain barrier (BBB)(Roh et al., 2016) as well as a lack of neurotrophic 
support for repair (Bansi et al., 2013; Wens et al., 2016; Zimmer et al., 2017). The outcome of 
CNS demyelination is associated with impaired nervous conduction and reduction in motoric and 
cognitive abilities (Mokhtarzade et al., 2017; Solari, 2015). 
The BBB monitors the entry of the essential and useful substance into the CNS, as well as 
restricting the passage of harmful substances (Ballabh et al., 2004; Obermeier et al., 2013; Roh et 
al., 2016). BBB dysfunction, either acute or chronic, results in the entry of harmful substances 
such as toxic metabolites, glucocorticoids (e.g. cortisol), pro-inflammatory cytokines (e.g. tumor 
necrosis factor alpha; TNFα), and immune cells into the CNS (Ortiz et al., 2014). This is seemingly 
a critical process in the pathophysiology of multiple sclerosis, as auto-reactive immune cells can 
enter the CNS during periods of BBB dysfunction and initiate the cascade of events resulting in 
demyelination and impaired repair (Larochelle et al., 2011; Ortiz et al., 2014). There are several 
methods of measuring BBB permeability and function (Côté et al., 2010; Montagne et al., 2015). 
A valid method that does not require magnetic resonance imaging (MRI), contrast agent injection, 
or cerebrospinal fluid (CSF) sampling is the monitoring of peripheral blood circulation markers of 
BBB function such as S100 calcium-binding protein B (s100b) and neuron-specific enolase (NSE) 
(Hoffmann et al., 2017; Roh et al., 2016). This issue is not limited to BBB markers.  Most 
techniques for monitoring immune markers and neurotrophic factors in the CNS require CSF 
sampling; it can be helpful, therefore to use CNS-related peripheral markers instead of CSF 
sampling. 
Regular physical activity, as a complementary therapeutic method (Mokhtarzade et al., 2017), 
that has been proposed as a putative disease modifying behavior in multiple sclerosis. A vast body 
of literature suggests positive effects of exercise on functional capacity, symptoms, and quality of 
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life outcomes (Motl et al., 2017) in pwMS. However, substantially less is known about its effect 
on multiple sclerosis pathophysiology including immune cells, cytokines, BBB function and 
neurotrophic factors (Motl et al., 2017; Wens et al., 2016; Zimmer et al., 2017). One of the reasons 
that may explain the uncertainty of the exercise effect on immune markers and neurotrophic factors 
is that exercise effects might depend on BBB permeability and/or weight status (Poduslo and 
Curran, 1996; Stranahan et al., 2009). Nevertheless, studies regarding the effect of exercise 
training on BBB permeability and related blood neurotrophic factors have not been conducted in 
overweight or obese multiple sclerosis patients. 
We conducted a randomized control trial (RCT) examining the effect of aerobic exercise 
training on BBB permeability markers, neurotrophic factors and cytokines, and further examined 
if weight status moderated the effect of exercise on these parameters. We hypothesized that 
exercise training vs. control would improve markers of BBB permeability, neurotrophic factors 
and cytokine profiles. We further hypothesized that weight status may affect markers of BBB 
permeability and neurotrophic factors following exercise training as well as cytokine status. To 
test this hypothesis, we recruited overweight and normal weight persons with multiple sclerosis 
and investigated the effect of interval exercise training on BBB permeability, cytokine profile, and 
neurotrophic factors in these persons compared with a non-exercise control condition. 
 
2. Materials and methods 
 
2.1. Participants 
The present study was approved by the Ethics Committee of Islamic Azad University of 
Abadan, Abadan, Iran and was performed in accordance with the Declaration of Helsinki. The 
full trial was conducted between Nov 2015 and May 2017. Participants with relapsing-remitting 
multiple sclerosis were recruited from Khuzestan multiple sclerosis center, Ahvaz, Iran. There 
were 108 relapsing-remitting multiple sclerosis patients with age > 22 years expressing an 
interest in participating in current study who were screened for inclusion criteria. All risks and 
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benefits of the present study were explained to participants, and then written informed consent 
was obtained.  
As illustrated in Figure 1, 103 of the 108 multiple sclerosis patients (Expanded Disability 
Status Scale; EDSS ≤ 4, age > 22 year) were eligible based on inclusion/exclusion criteria (8 did 
not meet inclusion/exclusion criteria). Subjects were excluded if they participated in another 
study or had: a) change immune modulatory therapy within the last six months; b) engaged in 
physical activity more than two hours per week; c) a relapse or acute multiple sclerosis 
exacerbation within the last four months; d) smoked; e) other chronic diseases (metabolic, 
cardiovascular, kidney or renal); and f) particular diet such as vegetarian.  
Of the 103 eligible participants, 54 participants had normal body weight status and 49 
participants were considered overweight based on BMI. We then randomly selected 66 
participants for participation, and 33 participants had normal weight status and 33 participants 
were overweight. These participants were randomly divided into exercise or control groups with 
a gender ratio of two:one (female:male) per group. Therefore, both the exercise and control 
groups included two subgroups of overweight and normal weight status. The groups included 
overweight training group (OW-trained, n=18), normal training group (NW- trained, n=18), 
overweight control group (OW- control, n=15), and normal control group (NW-control, n=15). 
During the intervention program one subject was lost to follow up from the NW- training group 
due to a relapse; one subject from the NW-control and the OW-trained group; and two subjects 
from the OW-control group were also lost to follow up due to being unwilling to continue in the 
study. Participant flow through recruitment/enrollment is included in the Consolidated Standards 
of Reporting Trials diagram (Figure 1).  
 
2.2. Procedures  
Pre-test data were collected from subjects before starting the exercise program. Pre-test 
data was also collected at the same time from the control group. Four days before starting the 
study, a venous blood sample was taken from the subjects in a seated position after 10 min rest. 
Next day, subjects performed a peak oxygen uptake (VO2peak) test as described previously (Storer 
et al., 1990). Although the assessors were blinded, based on nature of the study, neither therapy 
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administrations nor subjects were blinded to group allocation. Furthermore, although both OW-
trained and NW-trained groups were enrolled in the 8-week interval exercise training group, 
neither of the OW-control and NW-control groups participated in any exercise training. After 
completing the training program or control period, all pre-test measures were repeated. The blood 
samples were taken two days after completing exercise training. Finally, the VO2peak test was 
performed three days after completing the training program. 
 
2.3. Training program 
The training program consisted of 8 weeks (three sessions per week) of upper- and lower-
body interval-training using a Monark 891E and 894E ergometers (Varberg, Sweden), 
respectively. Each session consisted of three phases. Firstly, subjects performed stretching and 
low-intensity cycling as a warm-up protocol (ten min). Secondly, the study participants completed 
the main body of the program consisting of three intervals of upper and lower extremity cycling. 
After completion of the interval training, stretching exercises were performed as a cool-down (ten 
min). The main body of the exercise program consisted of three intervals (two min active and two 
min inactive rest) in week one and gradually increased to six intervals in week 8. It should be noted 
that intervals were considered separately for upper and lower limbs. The training load was adjusted 
by watt peak (Wpeak) determined by the VO2peak test. Training load started at 60% Wpeak during the 
first week and increased 5% Wpeak for each two weeks and eventually reached 75% Wpeak in the 
eighth week. During all sessions, the pedal rate was fixed at 50 rpm. The lower and upper limbs 
Wpeak was determined as described previously (Sawka et al., 1983; Storer et al., 1990). During all 
training sessions, heart rate was recorded and found to be between 60% and 80% maximal heart 
rate in active intervals. The session duration was incremental between 42 and 66 min 
(supplementary materials Figure 1).  
The control groups did not participate in any regular exercise program and were instructed 
to continue routine exercise and lifestyle behaviors. The control groups only completed pre-post 
outcome assessments. This condition was selected as a control for passage of time, maturation, 
and testing as confounders toward the internal validity of our experiment, but it did not account 
for social contact and attention as other confounders toward internal validity. A control group is 
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appropriate for this early stage of research, but future research might consider a minimal exercise 
condition such as supervised stretching for controlling other possible influences on study 
outcomes. 
 
2.4. Body mass index 
In this study, overweight body status is referred to as a person with a body mass index 
(BMI) above 25 kg/m2. Body weight, height, and BMI were measured before and after the 
intervention period in 10-h fasting. BMI (kg/m2) derived from the body mass (kg, Seca515, 
Sweden) divided by the square of height (m) of an individual. 
 
2.5. Neurotrophic factors and cytokines assessment 
Venous blood samples were collected in a clotted blood tube (BD Vacutainer Plus SST) 
before and after the eight-week training intervention after 10-h of fasting (between 8 and 9 a.m.). 
Subsequently, samples were centrifuged (3000 g for 12 min at 4 °C). Aliquots of serum were stored 
in Eppendorf tubes at -80℃ until analysis. Serum level of brain-derived neurotrophic factor 
(BDNF), nerve growth factor (NGF) was determined by enzyme-linked immunosorbent assay 
(ELISA) kits according to the manufacturer's instructions (R&D Systems, Minneapolis, USA). 
The serum level of ciliary neurotrophic factor (CNTF), and platelet-derived growth factor (PDGF) 
was determined by IBL International GMBH kit (Hamburg, Germany) according to the 
manufacturer's instructions. To determine serum level of cytokines (TNFα and interleukin 10; IL-
10), IBL International GMBH kit (Hamburg, Germany) was used according to the manufacturer's 
instructions. A microplate reader (Biochrom, Cambridge, UK) was used to measure absorbance at 
450 nm for quantification. Neurotrophic factors and cytokines coefficients of variation (CVs) were 
less than 8%. Serum level of cortisol was calculated by DiaMetra ELISA kit (Milano, Italy) with 
a CV equal to 6.5%.  
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2.6. BBB permeability markers 
To illustrate BBB permeability status, s100b and NSE were used. Serum levels of s100b 
reflected BBB permeability and deterioration and therefore may predict brain injury severity 
(Roh et al., 2016; Roh et al., 2017). In addition, NSE is reflective of neuron damage, neuron 
destruction, ischemic damage, and structural impairments in neuronal cell walls (Marchi et al., 
2004; Roh et al., 2017). In numerous studies, s100b is considered as the best indicator for BBB 
permeability and deterioration (Koh and Lee, 2014; Marchi et al., 2004; Roh et al., 2017), 
however, NSE often is considered as neuronal, but is often used as a nonspecific marker of BBB 
permeability (Marchi et al., 2004; Marchi et al., 2003; Roh et al., 2017). In the present study, the 
serum levels of s100b and NSE were determined by ELISA kit (Abnova, Taiwan and Alpha 
diagnostic, USA, respectively) and CVs were less than 8%. 
 
2.7. Data analysis 
Statistical analyses were performed using SPSS Statistics 21. After creating change scores 
for study outcomes based on the difference between pre- and post-test scores (post-test subtraction 
from pre-test), two-factor ANOVA (weight status: 2 levels of normal weight and overweight, 
conditions: 2 levels of exercise training and control) was used to investigate the effect of exercise 
training and weight status on changes of neurotrophic factors, BBB permeability, and cytokines or 
baseline levels of these factors. Partial Eta squared (ηp2) was used to determine effect size in 
ANOVA tests. The Bonferroni test was applied for all analyses that needed a post-hoc test. An 
alpha level of 0.05 was considered to be statistically significant (P≤0.05).  
 
3. Results 
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3.1. Baseline characteristics  
There were no significant differences between conditions in the baseline demographic 
characteristics including age, EDSS and disease duration (P>0.05). VO2peak was significantly 
higher in normal weight subjects when compared with overweight subjects (P<0.05, Table 1).  
Baseline neurotrophic analysis indicated that only BDNF showed a significant difference 
(P<0.05), however, no significant difference was observed for any other neurotrophic factors 
(P>0.05). Furthermore, NSE data were significantly higher in overweight subjects (P<0.05) while 
there was no baseline difference for cytokine profile (P>0.05, Table 2). 
 
3.2. Effect of exercise training on neurotrophic factors and BBB permeability 
The two-factor ANOVA test indicated that BDNF changes had significant weight (95% 
Confidence Interval (CI)= -4.3 to 0.5 ng/ml, ηp2: 0.394), training (95% CI= -2.4to 2.1 ng/ml, ηp2: 
0.543), and interaction effects (95% CI= 10.4 to 16.9 ng/ml, ηp2: 0.556). Post-hoc analysis 
indicated that BDNF increased significantly in NW-trained compared with other groups (Figure 
2A). There were no effects or interactions on NGF and CNTF (Figure 2B and C). There were 
significant weight (95% CI= -76.8 to 39.4 pg/ml, ηp2: 0.74), training (95% CI= 31.4  to 142.6 
pg/ml, ηp2: 0.541), and interaction (95% CI= 42.4 to 198.2 ng/ml, ηp2: 0.144) effects for PDGF 
changes. Both NW-trained and OW-trained had significant increases in PDGF compared with the 
control groups, and NW-trained had significantly higher increasing than OW-trained (Figure 2D, 
supplementary materials Table 2). 
S100b changes, had significant weight (95% CI= -8.3- to 4.8 pg/l, ηp2: 0.123), training 
(95% CI= -12.7 to -0.07pg/l, ηp2: 0.297), and interaction (95% CI= -18.8 to -0.10 pg/l, ηp2: 0.067) 
effects (Figure 2E). On the other hand, NSE changes indicated no significant effect (Figure 2F). 
Post-hoc analysis for s100b demonstrated that s100b decreased significantly more in NW-trained 
rather than other groups. 
 
3.3. Effect of exercise training on cytokines profile, cortisol and Vo2peak 
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TNFα (95% CI= -0.4 to 0.19 pg /ml, ηp2: 0.061) demonstrated a significant weight status 
effect. This was demonstrated by the normal weight group experiencing more decrease compared 
to the overweight group. IL-10 and cortisol did not demonstrate any weight effect (Figure 3). In 
the current study, IL-10/TNFα ratio was used as a parameter reflecting anti-inflammatory status 
(Mokhtarzade et al., 2017). We observed that the IL-10/TNFα ratio did not demonstrate any 
significant main effects or interaction. On the other hand, none of the mentioned factors had any 
training and/or interaction effect. VO2peak only indicated a training effect (Figure 4). The VO2peak 
increase was significantly higher in NW-trained and OW-trained compared to NW-control and 
OW-control groups. Finally, VO2peak remained significantly higher after the training program 
(supplementary materials Table 1). 
 
4. Discussion 
 
This is the first study investigating the physiological response of MS relevant biomarkers 
depending on subjects` weight status. We assumed that weight classification can be considered as 
a moderating factor for the effects of exercise on BBB function and neurotrophins in people with 
MS. Therefore, we conducted a RCT that examined the effects of 8 weeks aerobic interval exercise 
training on changes in disease modifying proteins including neurtotrophic factors (BDNF, NGF, 
CNTF and PDGF), cytokines (TNFα and IL-10), cortisol and BBB function markers (s100b and 
NSE) associated with MS between groups who differed in weight status (normal weight and 
overweight). To examine our hypothesis, 33 overweight patients and 33 normal weight patients 
were recruited and assigned into two conditions of exercise and control. Overall, exercise resulted 
in an increase of the neurotrophic factors, especially BDNF and PDGF depending on weight status; 
the highest increase in the levels of these two factors was observed in the normal weight 
participants who were involved in the exercise program. We further observed the effects of 
exercise on BBB permeability markers (S100b and NSE) indicating that participants with normal 
weight may be more adaptable for improving BBB permeability markers, especially s100b, to 
exercise training compared to overweight participants.  
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4.1. Exercise-Related Neurotrophic Factors Modulation  
Results suggested that exercise training may enhance circulating levels of BDNF and 
PDGF; however, body weight influenced the effect of exercise on these two neurotrophic factors. 
The results of our study suggest that overweight participants had a blunted increase in BDNF and 
PDGF following exercise training compared to normal weight participants. Moreover, exercise 
training had no significant effect on CNTF and NGF. Previous studies strongly confirm that BDNF 
is a critical factor in myelin repair, and positively affects neuronal and axonal survival (Arora, 
2006; Castellano et al., 2007; Onuoha et al., 1998). Therefore, upregulation of BDNF and 
increased serum levels of this factor can be a positive indicator for the role of exercise training in 
people with multiple sclerosis (Bansi et al., 2013; Castellano et al., 2007). Our findings are 
consistent with previous studies. For instance, Wens et al., and Bansi et al., reported that resistance 
training and aquatic training improve BDNF concentration in multiple sclerosis subjects, 
respectively (Bansi et al., 2013; Wens et al., 2016). Taken together, the few existing studies are in 
line with the present study, but our study expands the current knowledge by investigating the effect 
of body weight on neurotropic factors in multiple sclerosis.  
Weight gain is associated with releasing leptin from adipose tissue which stimulates pro-
inflammatory cytokines produced from T helper 1 cells such as TNFα (Majdinasab et al., 2018; 
Mokhtarzade et al., 2017). In addition, there are more macrophages, T cells, and inflammatory 
molecules connected with more subcutaneous adipose tissues (Esser et al., 2014). Therefore, 
obesity and multiple sclerosis are both associated with chronic inflammation that can together 
increase the severity of these conditions. Therefore, it can be concluded that the inflammation in 
overweight subjects observed in the previous studies can be attributed to lower efficacy of exercise 
training on neurotrophic factors (Roh et al., 2016). However, we observed that TNFα and IL-10 
concentrations and IL-10/TNFα ratio did not statistically differ between normal weight and 
overweight participants.  
These same studies suggest that BNDF is modifiable by metabolic markers (Levinger et 
al., 2008). It has been reported that obese people have lower BDNF levels compared to healthy 
controls (Lommatzsch et al., 2005); which was also observed in the current study. Based on this 
data, it can be assumed that some metabolic changes may impede the adaptation of BDNF to 
exercise (Levinger et al., 2008). Although studies have not been conducted on the effect of exercise 
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training on obese or overweight multiple sclerosis patients, previous studies on otherwise healthy 
obese individuals have shown that BDNF changes are closely associated with changes in body 
composition such as weight loss (Levinger et al., 2008). The lack of change in body composition 
in our study may provide a rationale as to why BDNF concentration was not impacted by the 
exercise intervention in obese multiple sclerosis participants. 
The improvement observed in PDGF for both overweight and normal weight participants 
represents another beneficial effect of exercise training; as it has been shown that a higher level of 
PDGF can reduce clinical consequences of damage in multiple sclerosis and increase progenitors 
and reversal of cell death in CNS (Huang and Dreyfus, 2016). Exercise research on PDGF is 
limited, Czarkowska-Paczek et al., found that endurance training enhanced PDGF expression in 
rat skeletal muscle (Czarkowska-Paczek et al., 2010); however, Trenerry et al, reported although 
acute exercise increased PDGF expression, there was no change after 12 weeks of resistance 
exercise (Trenerry et al., 2011). The reason for the inconsistency of the results may be attributed 
to the type of exercise (endurance vs. resistance), the species (rat vs. human), and the assessment 
of tissue (serum vs. muscle tissue). 
 
4.2. Exercise-Induced Alternation in BBB Permeability 
A previous investigation on BBB in obese participants clearly indicated that BBB 
permeability was significantly higher than healthy control participants with normal weight (Roh 
et al., 2016). In line with previous studies (Roh et al., 2016), we showed that NSE was higher in 
overweight subjects at the baseline. A potential explanation for this issue is that obesity is 
associated with more reactive oxygen species (ROS) activity, which can be considered as a 
potential mechanism for greater BBB permeability (Roh et al., 2016). Additionally, the activity 
of pro-inflammatory cytokines and matrix metalloproteinases are known to play a crucial role in 
the function of the BBB (Rochfort et al., 2014; Zimmer et al., 2017). Therefore, the reduction in 
ROS and pro-inflammatory cytokines can be considered as strategies to maintain or restore BBB 
integrity. In these published studies, exercise was used as an effective strategy to modulate 
cytokines associated with BBB disruption (Rochfort et al., 2014; Roh et al., 2016; Zimmer et al., 
2017). Our results also show that BBB permeability indicator reflected by s100b significantly 
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decreased after eight weeks of training. Bodyweight also seems to effect s100b concentrations in 
response to exercise training with s100b reduction significantly higher in NW-trained than other 
groups. In the current study, although cytokine levels did not move toward reducing 
inflammation, it can be deduced that by reducing BBB permeability, their progression and 
immune cells infiltration into the CNS has decreased, which can reduce CNS inflammation and 
lead to less neural damage (Raj et al., 2015). Moreover, previous data reported that PDGF can 
play an important role in the regulation of BBB permeability, and suggest potential strategies for 
treatment of non-multiple sclerosis patients (Raj et al., 2015). Therefore, greater increases of 
PDGF levels in the NW-trained group could be another reason for promote BBB permeability 
that was observed in the NW-trained group. 
Importantly, a decrease in BBB permeability reduces the entry of glucocorticoids such as 
cortisol from the peripheral blood circulation to the CNS (Li et al., 2014). Cortisol is associated 
with greater numbers of active lesions and less remyelinated plaques. Therefore, less cortisol 
crossing the BBB promotes the possibility of remyelination and promoting immunodulatory 
function in the CNS (Moghadasi and Najafi, 2017). 
Studies indicate that NSE concentration is indicative of brain and neural damage 
(Hoffmann et al., 2017; Marchi et al., 2004; Marchi et al., 2003; Roh et al., 2016). Furthermore, 
when there are both brain damage and BBB permeability, both s100b and NSE levels increase 
(Roh et al., 2016; Wu et al., 2016). Therefore, our results indicate that the effect of exercise in our 
subjects likely improved BBB permeability, but was not effective in reducing brain damage. As it 
is strongly evidenced that BBB destruction in multiple sclerosis patients is an introduction to brain 
damage (Cramer et al., 2014), reinforced BBB function may also be a viable mechanism 
demonstrating improvements in brain damage. Therefore, if the training period continues in 
patients, the results would be accompanied by a possible improvement in cerebral function 
markers. However, to reject or confirm this assumption, there is a need for further study with a 
longer training period. 
 
4.3. Limitation  
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 The current study has some limitation. Some of the evaluated markers in the current study 
are secreted from a variety of tissues. For example, BDNF is released from the brain, muscle, and 
some immune cells (Huang et al., 2014; Huang and Dreyfus, 2016; Onuoha et al., 1998). 
Considering that the evaluation of BDNF in the brain needs a cerebrospinal fluid sample or its 
evaluation in muscle requires biopsy. Collection of these bio specimens in multiple sclerosis 
patients can be painful; therefore, one of the limitations of this study is the lack of sampling of 
cerebrospinal fluid or muscle tissue. 
Determining obesity can be done by a wide range of measures; BMI was used in the current 
study to determine weight status of participants. Although, BMI is one of the most common 
method to classification body type, it does not provide exact information on body composition 
(Frankenfield et al., 2001). Therefore, it is recommended to use further relatively straightforward 
methods (i.e. waist to hip circumference ratio) in combination with BMI in future studies to avoid 
this limitation.  
There are several methods and techniques for determining the permeability of the BBB, 
which is a golden dynamic contrast-enhanced MRI (DCE-MRI) technique. Although the DCE-
MRI has been used in numerous studies (Barnes et al., 2016; Côté et al., 2010; Montagne et al., 
2015), it has been shown that peripheral markers (i.e. s100b) can also be suitable markers of BBB 
permeability (Hoffmann et al., 2017).  
A final limitation is the lack of a healthy control group that could help to interpret the 
results. Moreover, the control condition did not receive any intervention, not even a minimal 
exercise treatment group using stretching and toning. This is important as the control condition 
only accounts for passage of time, maturation, and change in instrumentation, and does not account 
for social contact or attention. Future research should include a better control condition. 
Eventually, due to the nature of the current study design, the social status of the subjects could 
possibly influence our outcomes. 
 
4.4. Conclusion 
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The current study indicates that 8 weeks of exercise training can stimulate BDNF and 
PDGF production and secretion in normal weight multiple sclerosis subjects. However, PDGF 
concentration increases were only observed in overweight multiple sclerosis subjects. Moreover, 
BBB permeability, as measured by s100b responded positively to exercise training in normal 
multiple sclerosis patients. Overall, exercise training can be an effective rehabilitation tool in 
people with multiple sclerosis, but current data demonstrated that the beneficial effects of exercise 
is restricted in overweight multiple sclerosis patients. Therefore, weight loss in overweight 
multiple sclerosis patients maybe important, and can be considered as the primary target of 
exercise training. Further comprehensive research is required to confirm the role of exercise on 
BBB permeability and examine the hypothesis that weight loss in people with multiple sclerosis 
can be considered as the primary target of exercise training. 
 
Conflict of Interest statement 
Mostafa Khodadust received support from Abadan Islamic Azad University, Abadan, Iran 
to perform current study. Other authors report no disclosures. 
 
References  
Arora, S., 2006. Role of neuropeptides in appetite regulation and obesity–a review. Neuropeptides 40, 
375-401. 
Ballabh, P., Braun, A., Nedergaard, M., 2004. The blood–brain barrier: an overview: structure, 
regulation, and clinical implications. Neurobiology of disease 16, 1-13. 
Bansi, J., Bloch, W., Gamper, U., Kesselring, J., 2013. Training in MS: influence of two different 
endurance training protocols (aquatic versus overland) on cytokine and neurotrophin concentrations 
during three week randomized controlled trial. Multiple Sclerosis Journal 19, 613-621. 
Barnes, S.R., Ng, T.S., Montagne, A., Law, M., Zlokovic, B.V., Jacobs, R.E., 2016. Optimal acquisition and 
modeling parameters for accurate assessment of low Ktrans blood–brain barrier permeability using 
dynamic contrast‐enhanced MRI. Magnetic resonance in medicine 75, 1967-1977. 
Castellano, V., Patel, D.I., Yarrow, J.F., McCoy, S.C., Blazina, A., White, L.J., 2007. Acute and chronic 
exercise influence serum brain-derived neurotrophic factor in multiple sclerosis. The FASEB Journal 21, 
A1370-A1370. 
Côté, J., Savard, M., Bovenzi, V., Dubuc, C., Tremblay, L., Tsanaclis, A.M., Fortin, D., Lepage, M., Gobeil, 
F., 2010. Selective tumor blood–brain barrier opening with the kinin B2 receptor agonist [Phe8ψ 
(CH2NH) Arg9]-BK in a F98 glioma rat model: An MRI study. Neuropeptides 44, 177-185. 
16 
 
Cramer, S.P., Simonsen, H., Frederiksen, J., Rostrup, E., Larsson, H.B.W., 2014. Abnormal blood–brain 
barrier permeability in normal appearing white matter in multiple sclerosis investigated by MRI. 
Neuroimage: Clinical 4, 182-189. 
Czarkowska-Paczek, B., Zendzian-Piotrowska, M., Bartlomiejczyk, I., Przybylski, J., Gorski, J., 2010. 
Skeletal and heart muscle expression of PDGF-AA and VEGF-A after an acute bout of exercise and 
endurance training in rats. Medical Science Monitor 16, BR147-BR153. 
Esser, N., Legrand-Poels, S., Piette, J., Scheen, A.J., Paquot, N., 2014. Inflammation as a link between 
obesity, metabolic syndrome and type 2 diabetes. Diabetes research and clinical practice 105, 141-150. 
Frankenfield, D.C., Rowe, W.A., Cooney, R.N., Smith, J.S., Becker, D., 2001. Limits of body mass index to 
detect obesity and predict body composition. Nutrition 17, 26-30. 
Hoffmann, J., Janowitz, D., Auwera, S., Wittfeld, K., Nauck, M., Friedrich, N., Habes, M., Davatzikos, C., 
Terock, J., Bahls, M., 2017. Association between serum neuron-specific enolase, age, overweight, and 
structural MRI patterns in 901 subjects. Translational psychiatry 7, 1272. 
Huang, T., Larsen, K., Ried‐Larsen, M., Møller, N., Andersen, L.B., 2014. The effects of physical activity 
and exercise on brain‐derived neurotrophic factor in healthy humans: A review. Scandinavian journal of 
medicine & science in sports 24, 1-10. 
Huang, Y., Dreyfus, C.F., 2016. The role of growth factors as a therapeutic approach to demyelinating 
disease. Experimental neurology 283, 531-540. 
Koh, S.X., Lee, J.K., 2014. S100B as a marker for brain damage and blood–brain barrier disruption 
following exercise. Sports Medicine 44, 369-385. 
Larochelle, C., Alvarez, J.I., Prat, A., 2011. How do immune cells overcome the blood–brain barrier in 
multiple sclerosis? FEBS letters 585, 3770-3780. 
Levinger, I., Goodman, C., Matthews, V., Hare, D.L., Jerums, G., Garnham, A., Selig, S., 2008. BDNF, 
metabolic risk factors, and resistance training in middle-aged individuals. Medicine & Science in Sports & 
Exercise 40, 535-541. 
Li, X., Wilder-Smith, C.H., Kan, M.E., Lu, J., Cao, Y., Wong, R.K., 2014. Combat training stress in soldiers 
increases S100B, a marker of increased blood brain barrier permeability and induces immune activation. 
Neuroendocrinology Letters 35, 58-63. 
Lommatzsch, M., Zingler, D., Schuhbaeck, K., Schloetcke, K., Zingler, C., Schuff-Werner, P., Virchow, J.C., 
2005. The impact of age, weight and gender on BDNF levels in human platelets and plasma. 
Neurobiology of aging 26, 115-123. 
Majdinasab, N., Motl, R.W., Mokhtarzade, M., Zimmer, P., Ranjbar, R., Keytsman, C., Cullen, T., 
Negaresh, R., Baker, J.S., 2018. Acute responses of cytokines and adipokines to aerobic exercise in 
relapsing vs. remitting women with multiple sclerosis. Complementary Therapies in Clinical Practice. 
Marchi, N., Cavaglia, M., Fazio, V., Bhudia, S., Hallene, K., Janigro, D., 2004. Peripheral markers of blood–
brain barrier damage. Clinica Chimica Acta 342, 1-12. 
Marchi, N., Rasmussen, P., Kapural, M., Fazio, V., Kight, K., Mayberg, M.R., Kanner, A., Ayumar, B., 
Albensi, B., Cavaglia, M., 2003. Peripheral markers of brain damage and blood-brain barrier dysfunction. 
Restorative neurology and neuroscience 21, 109-121. 
Moghadasi, M., Najafi, P., 2017. The effect of yoga training on enhancement of Adrenocorticotropic 
hormone (ACTH) and cortisol levels in female patients with multiple sclerosis. Complementary therapies 
in clinical practice 26, 21-25. 
Mokhtarzade, M., Ranjbar, R., Majdinasab, N., Patel, D., Shamsi, M.M., 2017. Effect of aerobic interval 
training on serum IL-10, TNFα, and adipokines levels in women with multiple sclerosis: possible relations 
with fatigue and quality of life. Endocrine, 1-10. 
Montagne, A., Barnes, S.R., Sweeney, M.D., Halliday, M.R., Sagare, A.P., Zhao, Z., Toga, A.W., Jacobs, 
R.E., Liu, C.Y., Amezcua, L., 2015. Blood-brain barrier breakdown in the aging human hippocampus. 
Neuron 85, 296-302. 
17 
 
Motl, R.W., Pilutti, L.A., 2012. The benefits of exercise training in multiple sclerosis. Nature Reviews 
Neurology 8, 487-497. 
Motl, R.W., Sandroff, B.M., Kwakkel, G., Dalgas, U., Feinstein, A., Heesen, C., Feys, P., Thompson, A.J., 
2017. Exercise in patients with multiple sclerosis. The Lancet Neurology 16, 848-856. 
Obermeier, B., Daneman, R., Ransohoff, R.M., 2013. Development, maintenance and disruption of the 
blood-brain barrier. Nature medicine 19, 1584-1596. 
Onuoha, G., Nicholls, D., Patterson, A., Beringer, T., 1998. Neuropeptide secretion in exercise. 
Neuropeptides 32, 319-325. 
Ortiz, G.G., Pacheco-Moisés, F.P., Macías-Islas, M.Á., Flores-Alvarado, L.J., Mireles-Ramírez, M.A., 
González-Renovato, E.D., Hernández-Navarro, V.E., Sánchez-López, A.L., Alatorre-Jiménez, M.A., 2014. 
Role of the blood–brain barrier in multiple sclerosis. Archives of medical research 45, 687-697. 
Poduslo, J.F., Curran, G.L., 1996. Permeability at the blood-brain and blood-nerve barriers of the 
neurotrophic factors: NGF, CNTF, NT-3, BDNF. Molecular Brain Research 36, 280-286. 
Raj, D.D., Moser, J., Pol, S., Os, R.P., Holtman, I.R., Brouwer, N., Oeseburg, H., Schaafsma, W., Wesseling, 
E.M., Dunnen, W., 2015. Enhanced microglial pro‐inflammatory response to lipopolysaccharide 
correlates with brain infiltration and blood–brain barrier dysregulation in a mouse model of telomere 
shortening. Aging cell 14, 1003-1013. 
Rochfort, K.D., Collins, L.E., Murphy, R.P., Cummins, P.M., 2014. Downregulation of blood-brain barrier 
phenotype by proinflammatory cytokines involves NADPH oxidase-dependent ROS generation: 
consequences for interendothelial adherens and tight junctions. PloS one 9, e101815. 
Roh, H.-T., Cho, S.-Y., So, W.-Y., 2016. Obesity promotes oxidative stress and exacerbates blood-brain 
barrier disruption after high-intensity exercise. Journal of Sport and Health Science. 
Roh, H.-T., Cho, S.-Y., Yoon, H.-G., So, W.-Y., 2017. Effect of Exercise Intensity on Neurotrophic Factors 
and Blood–Brain Barrier Permeability Induced by Oxidative–Nitrosative Stress in Male College Students. 
International journal of sport nutrition and exercise metabolism 27, 139-146. 
Sawka, M.N., Foley, M.E., Pimental, N.A., Toner, M.M., Pandolf, K.B., 1983. Determination of maximal 
aerobic power during upper-body exercise. Journal of applied Physiology 54, 113-117. 
Solari, A., 2015. Providing information for newly diagnosed people with multiple sclerosis. Journal of the 
Neurological Sciences 357, e474. 
Storer, T.W., Davis, J.A., Caiozzo, V.J., 1990. Accurate prediction of VO2max in cycle ergometry. Medicine 
and Science in Sports and Exercise 22, 704-712. 
Stranahan, A.M., Lee, K., Martin, B., Maudsley, S., Golden, E., Cutler, R.G., Mattson, M.P., 2009. 
Voluntary exercise and caloric restriction enhance hippocampal dendritic spine density and BDNF levels 
in diabetic mice. Hippocampus 19, 951-961. 
Trenerry, M.K., Della Gatta, P.A., Larsen, A.E., Garnham, A.P., Cameron‐Smith, D., 2011. Impact of 
resistance exercise training on interleukin‐6 and JAK/STAT in young men. Muscle & nerve 43, 385-392. 
Wens, I., Keytsman, C., Deckx, N., Cools, N., Dalgas, U., Eijnde, B.O., 2016. Brain derived neurotrophic 
factor in multiple sclerosis: effect of 24 weeks endurance and resistance training. European journal of 
neurology 23, 1028-1035. 
Wu, H., Brown, E.V., Acharya, N.K., Appelt, D.M., Marks, A., Nagele, R.G., Venkataraman, V., 2016. Age-
dependent increase of blood–brain barrier permeability and neuron-binding autoantibodies in S100B 
knockout mice. Brain research 1637, 154-167. 
Zimmer, P., Bloch, W., Schenk, A., Oberste, M., Riedel, S., Kool, J., Langdon, D., Dalgas, U., Kesselring, J., 
Bansi, J., 2017. High-intensity interval exercise improves cognitive performance and reduces matrix 
metalloproteinases-2 serum levels in persons with multiple sclerosis: A randomized controlled trial. 
Multiple Sclerosis Journal, 1352458517728342. 
 
18 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figures legend 
 
Figure 1. Flowchart of experimental design and subjects included. 
 
 
Figure 2. Effect of exercise training on neurotrophic factors and blood-brain barriers 
permeability. 
 * refers to significant difference between groups. NW-trained: normal training group, NW-
control: normal control group, OW-trined: overweight training group, OW-control: overweight 
control group, BDNF: Brain-derived neurotrophic factor, NGF: Nerve growth factor, CNTF: 
Ciliary neurotrophic factor, PDGF: Platelet-derived growth factor, S100b: S100 calcium-binding 
protein B, NSE: neuron-specific enolase. 
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Figure 3. Effect of exercise training on cytokine profile and cortisol concentration.  
NW-trained: normal training group, NW-control: normal control group, OW-trined: overweight 
training group, OW-control: overweight control group, TNF-a: Tumor necrosis factor alpha, IL-
10: Interleukin 10. 
 
 
Figure 4. Effect of exercise training on Vo2peak and body composition.  
NW-trained: normal training group, NW-control: normal control group, OW-trined: overweight 
training group, OW-control: overweight control group, BMI: body mass index, Vo2peak: peak 
oxygen consumption. 
 
